Medicine & Life Sciences
Thromboxanes
100%
Lysosomes
91%
Anticoagulants
89%
N-terbutyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea
86%
Keratinocytes
84%
Thromboxane Receptors
79%
Sleep
71%
Dabigatran
67%
Thrombin
67%
Thromboxane A2
61%
Rivaroxaban
55%
Epidermis
54%
SARS Virus
52%
Hyaluronic Acid
48%
Pharmaceutical Preparations
48%
Pharmacology
47%
Coumarins
45%
Hemostasis
45%
Neoplasms
44%
Thrombosis
43%
Hyaluronoglucosaminidase
43%
Liver
42%
Proteins
40%
In Vitro Techniques
40%
Blood Platelets
40%
Brain
40%
Therapeutics
38%
Extracellular Vesicles
36%
Nanoparticles
36%
Membranes
35%
Endocytosis
35%
Carbonic Anhydrase Inhibitors
34%
Memory
33%
Amyotrophic Lateral Sclerosis
33%
Enzymes
33%
Organelles
32%
Genes
32%
Prostaglandin H2 Receptors Thromboxane A2
32%
Heparin
32%
Schizosaccharomyces
30%
factor XIIa inhibitor
30%
Demyelinating Diseases
29%
Hemorrhage
28%
Factor XIIa
28%
Factor Xa Inhibitors
27%
Prothrombin Time
27%
Urea
27%
Magnetic Resonance Imaging
27%
Swine
26%
Torsemide
26%
Cyclooxygenase 2 Inhibitors
26%
Injections
26%
Lipids
26%
Platelet Aggregation
25%
Survival
24%
Sulfonamides
24%
apixaban
24%
aristolochic acid I
24%
Protein-Tyrosine Kinases
24%
Kidney
24%
Motor Neurons
24%
Tryptophan Oxygenase
24%
Cholesterol
24%
Messenger RNA
23%
Thromboplastin
23%
Indoleamine-Pyrrole 2,3,-Dioxygenase
23%
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
23%
BM 567
23%
Antibodies
22%
Lung
22%
Carbonic Anhydrases
22%
Endothelial Cells
21%
Paroxysmal Hemoglobinuria
21%
Chronic Obstructive Pulmonary Disease
21%
lysosomal proteins
21%
Gene Expression
21%
Inflammation
21%
ATP-Binding Cassette Transporters
21%
Atherosclerosis
20%
Blood Vessels
20%
Cyclodextrins
20%
Prostaglandin-Endoperoxide Synthases
20%
Learning
20%
Carbonic Anhydrase IX
20%
Apoptosis
20%
Hydrolases
20%
REM Sleep
20%
Endosomes
20%
Epoprostenol
20%
Atopic Dermatitis
19%
Indoles
19%
Cathepsin C
19%
Thrombocytopenia
19%
Nanostructures
19%
Cell Death
19%
Solubility
19%
Arachidonic Acid
19%
Sucrose
18%
Endoplasmic Reticulum
18%
Isopycnic Centrifugation
18%
Chemical Compounds
Thromboxane
61%
Thromboxane Synthase Inhibitor
57%
Anticoagulant Agent
57%
Protein
55%
Tryptophan
50%
Drug
47%
Thromboxanes A
47%
Thromboxane A2
43%
Thromboxane A2 Receptor Blocking Agent
43%
Isopycnic Centrifugation
37%
Torasemide
35%
Thrombin
32%
Plasma
31%
Antagonist
30%
Nanoparticle
29%
Coagulation
29%
Sulfonamide
27%
Molecule
27%
Arachidonic Acid
27%
Dose
26%
Time
25%
Corroles
24%
Coumarins
24%
Rivaroxaban
22%
Resistance
22%
Disorder
22%
Corrole
21%
Structure-Activity Relationship
20%
Glycyl-L-Phenylalanine 2-Naphthylamide
20%
Indoles
20%
Prostanoid
19%
EC 3.4.21.5 (Thrombin) Inhibitor
19%
Aristolochic Acid
19%
Differential Centrifugation
19%
Molecular Modeling
19%
Radioactivity
18%
Nanomaterial
18%
Cholesterol
18%
Agent Interacting With Transmitter, Hormone or Drug Receptor
17%
Marker
17%
Sucrose
17%
Cell Death
17%
Lipid
16%
Thromboxane Receptor Blocking Agent
16%
Biosynthesis
16%
Centrifugation
16%
Phosphatidylinositol 3 Kinase Inhibitor
16%
Serine
14%
Anticonvulsant
14%
Monoamine
14%
Auxin
13%
Fission
13%
Indole
13%
EC 1.4.3.4 (Monoamine Oxidase) Inhibitor
13%
Application
12%
Nonsteroid Antiinflammatory Agent
12%
Oxidative Stress
12%
Urea
12%
Kynurenine
11%
Coumarin
11%
Subcellular Localization
11%
Crystal Structure
11%
Monolayer
11%
Antithrombocytic Agent
11%
Safety
11%
Sonication
11%
Harmine
11%
Pharmacological Metabolism
10%
pH Value
10%
Acid
10%
Solubility
10%
Bioactivity
10%
Electronic Property
10%
Multi Walled Nanotube
9%
Macromolecule
9%
Protein C
9%
Substitution Reaction
9%
Hyaluronic Acid
9%
Thromboxane A2 Receptor Stimulating Agent
9%
Procoagulant
9%
Communication
9%
Nimesulide
9%
Metabolic
9%
Enzyme Inhibitor
9%
Dabigatran
9%
Mutation
9%
Convulsion
9%
Pharmaceutical
9%
Pharmacological Effect
8%
Thrombotic
8%
Proton-Induced X-Ray Emission
8%
Histone
8%
Ester
8%
Compound Isomer
8%
4-Hydroxycoumarin
8%